KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Account Payables: 2009-2020

Historic Change in Account Payables for Thermo Fisher Scientific (TMO) over the last 11 years, with Dec 2020 value amounting to $279.0 million.

  • Thermo Fisher Scientific's Change in Account Payables rose 42.35% to $279.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $59.0 million, marking a year-over-year decrease of 77.82%. This contributed to the annual value of $212.0 million for FY2024, which is 142.40% up from last year.
  • As of Q4 2020, Thermo Fisher Scientific's Change in Account Payables stood at $279.0 million, which was up 0.72% from $277.0 million recorded in Q3 2020.
  • Over the past 5 years, Thermo Fisher Scientific's Change in Account Payables peaked at $279.0 million during Q4 2020, and registered a low of -$256.0 million during Q2 2020.
  • Moreover, its 3-year median value for Change in Account Payables was $24.5 million (2018), whereas its average is $43.8 million.
  • Within the past 5 years, the most significant YoY rise in Thermo Fisher Scientific's Change in Account Payables was 2,812.87% (2017), while the steepest drop was 1,374.51% (2017).
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Change in Account Payables stood at -$10.1 million in 2016, then skyrocketed by 2,812.87% to $274.0 million in 2017, then declined by 10.22% to $246.0 million in 2018, then fell by 20.33% to $196.0 million in 2019, then surged by 42.35% to $279.0 million in 2020.
  • Its Change in Account Payables was $279.0 million in Q4 2020, compared to $277.0 million in Q3 2020 and -$256.0 million in Q2 2020.